Lentivirus Infections disease is an indication for drug development with over 520 pipeline drugs currently active according to GlobalData.
Novo to buy mid-stage heart failure biotech Cardior for up to $1.1B
Novo Nordisk plans to acquire German biotech Cardior Pharmaceuticals, a Phase 2 RNA startup, for up to $1.1 billion to boost its presence in cardiovascular disease, the